Detalles de la búsqueda
1.
[The mechanism of topotecan resistance in ovarian cancer cell line].
Zhonghua Zhong Liu Za Zhi
; 26(3): 139-42, 2004 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-15196431
2.
[Correlation of expression of RhoA (RhoC and their effector ROCK-1 with malignant phenotype of ovarian cancer cells in vitro].
Zhonghua Zhong Liu Za Zhi
; 26(7): 385-8, 2004 Jul.
Artículo
en Zh
| MEDLINE | ID: mdl-15355639
3.
[Significance of expression of T lymphoma invasion/metastasis gene in ovarian cancer cells].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
; 25(4): 434-7, 2003 Aug.
Artículo
en Zh
| MEDLINE | ID: mdl-12974090
4.
Establishment and characterization of cell sublines with high and low metastatic potential derived from human osteosarcoma.
Chin Med J (Engl)
; 118(8): 687-90, 2005 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-15899125
5.
[Effects of chemokine receptor and its ligand on migration of ovarian cancer cells].
Ai Zheng
; 24(1): 23-7, 2005 Jan.
Artículo
en Zh
| MEDLINE | ID: mdl-15642195
6.
[Inhibitory effect of MT1-MMP antisense nucleotide on invasion of human highly metastatic ovarian cancer cell line SW626].
Ai Zheng
; 23(11): 1263-6, 2004 Nov.
Artículo
en Zh
| MEDLINE | ID: mdl-15522170
7.
[Antisense oligonucleotide reverses topotecan-resistant ovarian cancer cells].
Ai Zheng
; 22(12): 1296-300, 2003 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-14693055
Resultados
1 -
7
de 7
1
Próxima >
>>